| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1060 |
| Trial ID | ChiCTR-ONC-16009889 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A single center, prospective, clinic study of anti-CD19 chimeric antigen receptor T cells treating refractory and relapsed children B acute lymphoblastic leukemia |
| Year | 2016 |
| Country | China |
| Company sponsor | Shanghai Children's Medical Center affiliated to Shanghai Jiao Tong University School of Medicine |
| Cohort 1 | |||||||
|
|||||||